Medicare Enrolled

Dr. James Brashears, MD

Radiology - Diagnostic · Seattle, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
540 26TH AVE, Seattle, WA 98122
9417264991
In practice since 2006 (19 years)
NPI: 1720177819 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brashears from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brashears? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brashears

Dr. James Brashears is a radiology - diagnostic specialist in Seattle, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Brashears performed 208 Medicare services across 61 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brashears received a total of $1,819 from 32 pharmaceutical and/or device companies across 91 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brashears is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 208 Medicare services $1,819 industry payments

Medicare Practice Summary

Medicare Utilization ↗
208
Medicare services
Bottom 8% in WA for radiology - diagnostic
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
61
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
CT guidance for radiation therapy
This procedure uses computed tomography imaging to guide the precise placement of radiation therapy fields. It ensures accurate positioning for targeted treatment delivery.
137 $107 $670
Continuing radiation therapy consultation per week
A weekly consultation to review and manage ongoing radiation therapy treatment.
36 $80 $263
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $50 $293
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $81 $430
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$1,819
Total received (2018-2022)
Avg $455/year across 4 years
Top 21% in WA for radiology - diagnostic
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
91
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,803 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$15
2021
$125
2019
$473
2018
$1,206

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$15
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2018-2022) ›
Novartis Pharmaceuticals Corporation
$161
Janssen Biotech, Inc.
$147
AstraZeneca Pharmaceuticals LP
$136
Myovant Sciences Inc.
$125
Bayer HealthCare Pharmaceuticals Inc.
$123
Celgene Corporation
$114
Amgen Inc.
$106
Lilly USA, LLC
$103
TESARO, Inc.
$73
Ipsen Biopharmaceuticals, Inc
$66
Dendreon Pharmaceuticals LLC
$61
Takeda Pharmaceuticals U.S.A., Inc.
$60
Exelixis Inc.
$53
Boston Scientific Corporation
$49
Helsinn Therapeutics (U.S.), Inc.
$49
E.R. Squibb & Sons, L.L.C.
$39
Blue Earth Diagnostics Limited
$36
Merck Sharp & Dohme Corporation
$34
Novocure Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Heron Therapeutics, Inc.
$24
Incyte Corporation
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
Shire North American Group Inc
$22
AbbVie, Inc.
$20
Jazz Pharmaceuticals Inc.
$20
GENZYME CORPORATION
$20
Midatech Pharma US Inc
$18
AMAG Pharmaceuticals, Inc.
$16
PFIZER INC.
$15
INSYS Therapeutics Inc
$14
Clovis Oncology, Inc.
$13
Top 3 companies account for 24.4% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AKYNZEO · ALIMTA · Abraxane · Aliqopa · Axumin · CALQUENCE · CINVANTI · CYRAMZA · Cabometyx · DARZALEX · ERBITUX · Erleada · FASLODEX · FERAHEME · GENERAL MALE SUI · GILOTRIF · Gelclair · IMBRUVICA · IMFINZI · JADENU · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · Neulasta · Nplate · OPDIVO · ORGOVYX · Oncology · PROVENGE · RELISTOR · Revlimid · Rubraca · SOMATULINE DEPOT · SUBSYS · Stivarga · TAGRISSO · TASIGNA · VYXEOS · Venclexta · Vitrakvi · XTANDI · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a radiology - diagnostic specialist in Seattle?
Compare radiology - diagnostics in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse radiology - diagnostics nearby

Geographic Context

Radiology - diagnostics within 10 mi
113
Per 100K population
5.0
County median income
$122,148
Nearest hospital
SWEDISH MEDICAL CENTER / CHERRY HILL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Brashears is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Brashears experienced with ct guidance for radiation therapy?
Based on Medicare claims data, Dr. Brashears performed 137 ct guidance for radiation therapy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brashears receive payments from pharmaceutical companies?
Yes. Dr. Brashears received a total of $1,819 from 32 companies across 91 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brashears's costs compare to other radiology - diagnostics in Seattle?
Dr. Brashears's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brashears) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →